Fig. 4From: Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patientsStudy flow (Study 2). Group 2A: 3 days of once daily IM injection SAR97276A (0.5 mg/kg or 36 mg). Group 2B: 3 days of 2 daily IM injections SAR97276A (every 12 h 0.25 mg/kg or 18 mg). Group 2C: 3 days oral ACT according to the countries recommendations, i.e. artemether–lumefantrineBack to article page